4.15.09 Pediatrics Grand Rounds Evaluation

1. Advances in ChaperoneTherapy and Pharmacogenetics

Jeanine Utz, PharmD, BCOP, BCPS
Advanced Therapies Clinical Pharmacist
Fairview Pharmacy Services
April 15, 2009

Teaching Objectives:
1. Define the general underlying the mechanisms of action of chaperone therapies
2. Recognize medical conditions that might be potential candidates for chaperone drug therapy
3. Understand the functional role of pharmacogenetics towards optimizing chaperone therapies

1. How well did this lecture fulfill the stated objectives?

How well did this lecture fulfill the stated objectives? Excellent

Very Good

Good

Fair

Poor

2. How current was the information presented?

How current was the information presented? Cutting Edge

Very Current

Adequately Current

Not Identifiable

3. Please rate the clinical applicability of the information presented.

Please rate the clinical applicability of the information presented. Extremely applicable

Very applicable

Somewhat applicable

Not very applicable

Not relevant to my practice

4. Please rate the speaker's quality of presentation.

Please rate the speaker's quality of presentation. Excellent

Very Good

Good

Fair

Poor

5. Was the presentation free of commercial bias?

Was the presentation free of commercial bias? Yes

6. Please use this space for general comments related to this presentation.

Please use this space for general comments related to this presentation.

7. We welcome your suggestions for future topics.

We welcome your suggestions for future topics.

Thank you for taking the time to complete this evaluation. Click the DONE button below to record your responses.

form {display:none;} #jserror {text-align:center;margin-top:50px;}Javascript is required for this site to function, please enable.